Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
Manufactured by
Jyvaskyla, Finland
BiopSense is developing a fully automated blood processing solution to help health care professionals, such as laboratories to solve the current complicated biopsy workflows with our unique cartridge technology. With the number of treatment options constantly increasing, more frequent monitoring helps the oncologists to respond more quickly in case the treatment is not satisfactory, or a drug resistance is induced. As a result, the patient will receive efficient treatment faster. Cancer medications are often expensive and predicting the effect could be hard, but they can also have the potential to completely cure the cancer. That is why it is important to find the correct medication right as soon as possible. Therefore, screening and constant monitoring for cancer with liquid biopsy is an effective way to improve the quality of cancer treatments and to reduce the burden of cancer. We aim to replace invasive sampling with a less and non-invasive option – liquid biopsy sampling - fully automated.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Burning Rock Dx Co. Ltd.
China · 8 relevant products
Qassay
United States · 1 relevant product
Intelligenome
United States · 1 relevant product
LifeOS Genomics Corporation
Taiwan · 1 relevant product
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 1 relevant product
Suzhou Rainsure Scientific Co., Ltd.
China · 1 relevant product
Atila BioSystems
United States · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 5 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 100 closest product alternatives
Burning Rock Dx Co. Ltd. · China
Multiplex immunoassay platform for detecting circulating cancer biomarkers in blood samples. Facilitates early diagnosis and treatment response monitoring in oncology patients.
Qassay · United States
Assay for detecting and quantifying cancer-related biomarkers. Supports early detection and monitoring through rapid point-of-care testing.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
LifeOS Genomics Corporation · Taiwan
Laboratory-developed test (LDT) for T790M gene detection in lung cancer patients using blood samples. Approved by Taiwan FDA, this assay replaces invasive tissue biopsy and identifies EGFR resistance mutations to guide third-generation drug selection.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for detecting drug-resistant mutations in Mycobacterium tuberculosis. Supports treatment selection and antimicrobial resistance monitoring.
Anbio Biotechnology Limited · Germany
Comprehensive testing suite for oncology biomarkers including CEA, AFP, and CA markers. Supports cancer diagnosis, prognosis, and treatment monitoring.
Suzhou Rainsure Scientific Co., Ltd. · China
Molecular assay for detecting EGFR gene mutations including 19-deletion variant in tissue and plasma circulating free DNA. Supports treatment selection and monitoring in non-small cell lung cancer patients.
Atila BioSystems · United States
A molecular assay designed for cervical cancer screening applications utilizing Atila BioSystems nucleic acid amplification chemistry.
guangzhou biotron technolongy co.,ltd · China
Liquid biopsy assay for real-time monitoring of circulating tumor markers and cells during perioperative periods to assess surgical outcomes and recurrence risk.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic assay utilizing circulating tumor cell and cell-free DNA analysis to support pulmonary nodule characterization and malignancy risk assessment.
88 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products